Picard Medical Highlights Business Progress, 85% Revenue Growth

Picard Medical, Inc. announced the availability of its pre-recorded presentation for the 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The presentation highlighted significant business progress, including an 85% year-over-year revenue increase and a 28% improved gross margin from year-end 2025. The company also provided updates on its next-generation Emperor platform, with plans for an Investigational Device Exemption submission in 2028 and clinical studies in 2029. Stockholders are encouraged to review proxy materials for proposals to be voted on at the meeting.